Intrinsiqs

Is Mirum Pharmaceuticals, Inc. overvalued?

Mirum Pharmaceuticals, Inc. (MIRM) — key valuation metrics and fundamentals.

No verdict
Price
$98.63
Fair value
Current P/E
Normal P/E
Market cap
$6.01B
Dividend yield
0.0%
Return on equity
-410.2%
Sector
Healthcare

See the full interactive analysis →

Fair value compares MIRM's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 11 Aug 2026.